S. Lippman

Molecular Biology · 2004–2021

A researcher in the Science corpus: 14 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom S. Lippman trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Adi F. Gazdar (in Pulmonary and Respiratory Medicine)

Papers from S. Lippman's perspective

Ordered by how strongly the researchers S. Lippman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Mutations of the BRAF gene in human cancer (Nature)
  2. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
  3. The RAF proteins take centre stage (Nature reviews. Molecular cell biology)
  4. Targeting RAS signalling pathways in cancer therapy (Nature Reviews. Cancer)
  5. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis (Cancer Research)
  6. BRAFE600-associated senescence-like cell cycle arrest of human naevi (Nature)
  7. BRAF mutation predicts sensitivity to MEK inhibition (Nature)
  8. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
  9. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. (Journal of Clinical Oncology)
  10. Signatures of mutational processes in human cancer (Nature)

Their papers